The Variability in Ultrafiltration Achieved with Icodextrin, Possibly Explained

Background A recent study by Jeloka et al. (Perit Dial Int 2006; 26:336–40) highlighted the high variability in maximum ultrafiltered volume (UFmax) and the corresponding dwell time (tmax) obtained using 7.5% icodextrin solution. We aimed to pinpoint the possible sources of this phenomenon by simulating the icodextrin ultrafiltration (UF) profiles according to the three-pore model of peritoneal transport. Method The individual UF time courses observed in the study by Jeloka et al. (n = 29) were first characterized by linear and quadratic regression. We were then able to identify four main patterns. These were then adapted to UF profiles generated by the three-pore model by systematically altering the values of some model parameters, namely, the mass transfer area coefficient (MTAC or PS) for icodextrin/glucose, the peritoneal UF coefficient (LpS), the plasma colloid osmotic pressure gradient (ΔΠ), and the macromolecular clearance out of the peritoneal cavity (ClLF). Results Modifications in the PS values caused only marginal variations in UFmax and tmax, while more significant changes were produced by altering LpS and ClLF. However, far more evident was the importance of changes in ΔΠ In fact, lowering ΔΠ to 14 mmHg caused a steady increase in UF with 10 – 14 hour dwells. On the contrary, the UF profiles became nearly “flat” when ΔΠ was increased to 30 mmHg. The parallel shifts induced by altering icodextrin metabolite concentrations did not markedly influence UFmax or tmax. Conclusion The UF pattern in icodextrin dwells seem to be mainly determined by the plasma colloid osmotic pressure, while only moderate changes can be seen with alterations in LpS and ClLF. The result is not completely unexpected considering that icodextrin acts by inducing a strong colloid osmotic gradient. A number of clinical studies would be needed, however, in order to prove this hypothesis.

[1]  T. Eleftheriadis,et al.  Significant Intra- and Interpatient Variation in Ultrafiltration Achieved by Icodextrin in APD Patients , 2007, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[2]  S. Davies,et al.  Mitigating peritoneal membrane characteristics in modern peritoneal dialysis therapy. , 2006, Kidney international. Supplement.

[3]  S. Davies Exploring new evidence of the clinical benefits of icodextrin solutions. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[4]  E. Vonesh,et al.  Modeling of Icodextrin in PD Adequest® 2.0 , 2006, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[5]  I. Karayaylali,et al.  What is the Optimal Dwell Time for Maximizing Ultrafiltration with Icodextrin Exchange in Automated Peritoneal Dialysis Patients? , 2006, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[6]  A. Werynski,et al.  Determination of High and Low Molecular Weight Molecules of Icodextrin in Plasma and Dialysate, Using Gel Filtration Chromatography, in Peritoneal Dialysis Patients , 2005, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[7]  B. Lindholm,et al.  Determination of α-Amylase Activity in Serum and Dialysate from Patients Using Icodextrin-Based Peritoneal Dialysis Fluid , 2003, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[8]  B. Rippe,et al.  Transport asymmetry in peritoneal dialysis: application of a serial heteroporous peritoneal membrane model. , 2001, American journal of physiology. Renal physiology.

[9]  B. Rippe,et al.  Computer simulations of ultrafiltration profiles for an icodextrin-based peritoneal fluid in CAPD. , 2000, Kidney international.

[10]  K. Nolph,et al.  Management of High Peritoneal Transporters , 2000, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[11]  T. Hannedouche,et al.  Prediction of colloid osmotic pressure in renal patients. , 2000, Clinical Nephrology.

[12]  H. Verbrugh,et al.  Serum Disaccharides and Osmolality in Ccpd Patients Using Icodextrin Or Glucose as Daytime Dwell , 1997, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[13]  N. Schouten,et al.  Peritoneal transport characteristics with glucose polymer based dialysate. , 1996, Kidney international.

[14]  J. Henriksen,et al.  Bidirectional peritoneal transport of albumin in continuous ambulatory peritoneal dialysis. , 1995, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[15]  D. Davies Kinetics of Icodextrin , 1994 .

[16]  R. Olshen,et al.  Relationships among protein and albumin concentrations and oncotic pressure in nephrotic plasma. , 1993, The American journal of physiology.

[17]  D. Zemel,et al.  Day-To-Day Variability of Protein Transport Used as a Method for Analyzing Peritoneal Permeability in CAPD , 1991, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[18]  Y. Bar-Khayim,et al.  Kinetics of peritoneal protein loss during CAPD: I. Different characteristics for low and high molecular weight proteins. , 1990, Kidney international.

[19]  Y. Bar-Khayim,et al.  Kinetics of peritoneal protein loss during CAPD: II. Lipoprotein leakage and its impact on plasma lipid levels. , 1990, Kidney international.

[20]  D. Young,et al.  Measurements of serum colloid osmotic pressure are of limited usefulness. , 1982, Clinical chemistry.